B cell localization: Regulation by EBI2 and its oxysterol ligand

Trends in Immunology

Volumn 34, Issue 7, 2013, Pages 336-341

  Gatto, Dominique ^a,b   Brink, Robert ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

antibody response; B cell migration; EBI2; oxysterol

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 183; OXYSTEROL; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BURKITT LYMPHOMA; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; GERMINAL CENTER; LYMPHOID TISSUE; NONHUMAN; PLASMA CELL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; TUMOR MICROENVIRONMENT; UPREGULATION;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELLULAR MICROENVIRONMENT; CHEMOTAXIS; GERMINAL CENTER; HUMANS; HYDROXYSTEROIDS; IMMUNITY, HUMORAL; PLASMA CELLS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84880838774     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.01.007     Document Type: Review

References (50)

1. Cyster J.G., et al. Follicular stromal cells and lymphocyte homing to follicles. Immunol. Rev. 2000, 176:181-193.
2. Förster R., et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996, 87:1037-1047.
3. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 2005, 23:127-159.
4. Okada T., Cyster J.G. B cell migration and interactions in the early phase of antibody responses. Curr. Opin. Immunol. 2006, 18:278-285.
5. Reif K., et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002, 416:94-99.
6. MacLennan I.C., et al. Extrafollicular antibody responses. Immunol. Rev. 2003, 194:8-18.
7. Gatto D., Brink R. The germinal center reaction. J. Allergy Clin. Immunol. 2010, 126:898-907.
8. Zotos D., Tarlinton D.M. Determining germinal centre B cell fate. Trends Immunol. 2012, 33:281-288.
9. Kelly L.M., et al. EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. J. Immunol. 2011, 187:3026-3032.
10. Coffey F., et al. Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles. Immunity 2009, 30:599-609.
11. Kerfoot S.M., et al. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity 2011, 34:947-960.
12. Kitano M., et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 2011, 34:961-972.
13. Chan T.D., et al. Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J. Immunol. 2009, 183:3139-3149.
14. Gatto D., et al. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity 2009, 31:259-269.
15. Hannedouche S., et al. Oxysterols direct immune cell migration via EBI2. Nature 2011, 475:524-527.
16. Liu C., et al. Oxysterols direct B-cell migration through EBI2. Nature 2011, 475:519-523.
17. Pereira J.P., et al. EBI2 mediates B cell segregation between the outer and centre follicle. Nature 2009, 460:1122-1126.
18. Birkenbach M., et al. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 1993, 67:2209-2220.
19. Rosenkilde M.M., et al. Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J. Biol. Chem. 2006, 281:13199-13208.
20. Surgand J.S., et al. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 2006, 62:509-538.
21. Glynne R., et al. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 2000, 176:216-246.
22. Shaffer A.L., et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000, 13:199-212.
23. Lam L.T., et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008, 111:3701-3713.
24. Yi T., et al. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 2012, 37:535-548.
25. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
26. Mueller S.N., et al. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 2007, 317:670-674.
27. Gatto D., et al. EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J. Immunol. 2011, 187:4621-4628.
28. Cyster J.G., Schwab S.R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 2012, 30:69-94.
29. Cyster J.G. B cell follicles and antigen encounters of the third kind. Nat. Immunol. 2010, 11:989-996.
30. Phan T.G., et al. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat. Immunol. 2007, 8:992-1000.
31. Chappell C.P., et al. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J. Exp. Med. 2012, 209:1825-1840.
32. Hargreaves D.C., et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 2001, 194:45-56.
33. Garcia De Vinuesa C., et al. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 1999, 29:3712-3721.
34. Kabashima K., et al. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450.
35. Mohr E., et al. Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J. Immunol. 2009, 182:2113-2123.
36. Green J.A., et al. The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat. Immunol. 2011, 12:672-680.
37. Victora G.D., et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 2010, 143:592-605.
38. Allen C.D., et al. Germinal-center organization and cellular dynamics. Immunity 2007, 27:190-202.
39. Heinig M., et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010, 467:460-464.
40. Ye S., et al. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology 2003, 42:1155-1163.
41. Cantor R.M., et al. Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum. 2004, 50:3203-3210.
42. Moser K.L., et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14869-14874.
43. Aalto Y., et al. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 2001, 15:1721-1728.
44. Ley T.J., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456:66-72.
45. Alizadeh A.A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
46. Shipp M.A., et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 2002, 8:68-74.
47. Kurth J., et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 2000, 13:485-495.
48. Niedobitek G., et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992, 79:2520-2526.
49. Benned-Jensen T., et al. Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183). J. Biol. Chem. 2012, 287:35470-35483.
50. Zhang L., et al. Identification of structural motifs critical for EBI2 function and homology modeling of ligand docking site. Mol. Pharmacol. 2012, 82:1094-1103.